Central serous chorioretinopathy in giant cell arteritis

Seminars in Ophthalmology
Vinay A ShahAndrew G Lee

Abstract

A 66-year-old woman started oral prednisone for temporal artery biopsy (TAB) proven GCA and developed central haziness OD > OS. Visual acuity worsened to 20/100 OD and 20/25 OS. Clinical exam, optical coherence tomography (OCT) and fluorescein angiography (FA) revealed central serous chorioretinopathy (CSCR). The patient was treated with focal laser therapy for CSCR and steroid taper. Patients with giant cell arteritis on high dose steroids may present with significant loss of visual acuity and field. CSCR (precipitated by steroids) should be considered in the differential diagnosis as increasing the steroid dose for presumed visual loss secondary to GCA might worsen rather than improve the visual outcome.

References

Jan 1, 1996·Ophthalmology·D A QuillenJ L Gottlieb
May 1, 1997·Japanese Journal of Ophthalmology·M WakakuraS Ishikawa
Nov 15, 2002·Survey of Ophthalmology·Evrydiki A BouzasConstantin J Pournaras
Jul 22, 2005·Clinical & Experimental Ophthalmology·Timothy BevisM Tariq Bhatti

❮ Previous
Next ❯

Citations

Sep 1, 2006·Photomedicine and Laser Surgery
Aug 18, 2010·Clinical Ophthalmology·Antonio CaccavaleFabio Ferentini
Jul 11, 2013·Case Reports in Ophthalmological Medicine·Andre Grixti, Vineeth Kumar
Apr 28, 2011·Arthritis Care & Research·Ahmad B TarabishyCareen Y Lowder
Mar 14, 2012·Ocular Immunology and Inflammation·Moncef KhairallahIlknur Tugal-Tutkun
Apr 27, 2016·International Ophthalmology·Ayhan DursunMustafa Kemal Arici

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.